BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Digene

A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests focused on women's cancers and infectious diseases. The company's flagship product, The Digene® HPV Test* (DNAwithPap® Test), is the only FDA–approved test for the human papillomavirus (HPV), the primary cause of cervical cancer. Rapidly emerging as a standard of practice in cervical cancer screening, the HPV test aids healthcare professionals in identifying women who are most at risk of having or developing cervical cancer, which today is the world's second–most–common type of cancer affecting women. Digene's product portfolio also includes DNA tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea, as well as tests for blood viruses. Through its own staff or affiliated distributors, Digene markets its tests in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE.


Contact Details:
1201 Clopper Road
Gaithersburg
MD
20878
United States of America
Tel:301 944 7000
Fax:240.632.7121
Email:inforeq@digene.com
WWW:

www.digene.com/




Loading...

Recent Publications by Digene:

Effect of sample aliquot size on the limit of detection and reproducibility of clinical assays.
BACKGROUND: Nucleic acid amplification technologies significantly improved...
19th December, 2007
Digene Corporation, Research and Development, Gaithersburg, MD 20878, USA. Clin Chem. 2007 Nov;53(11):1962-5. Epub 2007 Aug 30.
DOI Direct Link
Homogeneous detection of nucleic acids using self-quenched polymerase chain reaction primers labeled with a single fluorophore (LUX primers).
Multiplex quantitative polymerase chain reaction (PCR) based on novel...
12th October, 2007
Research and Development, Digene Corporation, Gaithersburg, MD, USA. Methods Mol Biol. 2006;335:95-114.
DOI Direct Link
HPV technologies advancing public health: discussion of recent evidence.
Effective primary and secondary cancer prevention programmes are key to...
20th July, 2007
International Public Affairs, Digene, Geneva, Switzerland. Coll Antropol. 2007 Apr;31 Suppl 2:55-60.
Cervical HPV DNA Detection as a Predictor of a Recurrent SIL Diagnosis Among Untreated Women.
OBJECTIVES: This study was conducted to test whether patient history of...
20th October, 2006
*Division of Cancer Epidemiology and Genetics, National Cancer Institute, J Low Genit Tract Dis. 2001 Jul;5(3):138-143.
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
We examined whether higher human papillomavirus type 16 (HPV16) viral load...
15th December, 2005
Digene Corporation, 1201 Clopper Road, Gaithersburg, MD 20878, USA. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1311-4.
DOI Direct Link

View more Digene research publications.

BioNews Results for Digene:

Future growth in IVDs to come from emerging markets
Medical Device Link:  Aug 27 2008 2:57PM Matching: digene
Legislators misguided about vaccine, researcher says (4)
KPC News:  Aug 23 2008 7:39AM Matching: digene
Biotech Avalon posts $5.6M loss, cuts jobs
Gazette.net:  Aug 20 2008 2:03PM Matching: digene
Research and Markets: The Molecular Diagnostics Market DNA Probes and Biochips: A 7-Country Market Survey
Business Wire via Yahoo!:  Aug 14 2008 2:54PM Matching: digene
Osmetech plc ('Osmetech' or the 'Company') Board changes
DiGiTAL50:  Aug 13 2008 11:56AM Matching: digene
Promote your company here: BioNewsCast - Press Release Distribution

View more Digene news.

Digene Patents:

US Patent No.Title
7399589 Immunological detection of RNA:DNA hybrids on microarrays
6277579 Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
6228578 Non-radioactive hybridization assay and kit
6225053 Detection of hepatitis B virus
6136535 Continuous amplification reaction

View more Digene patents.

Digene (DIGE) Financial information Links from Barchart

DIGE Quote from from Barchart.com
DIGE Chart from from Barchart.com
DIGE Profile from from Barchart.com
DIGE Opinion from from Barchart.com

View more Digene finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 195 times since April 2007, the link to the organisation's website has been followed 50 times

Recent Search Terms used to find this page: digene.com | digene | @digene.com | .

Search for more companies in Gaithersburg

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Digene
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.